Can serum free light chain determination replace detection and quantitation of Bence Jones proteinuria in clinical practice?;La determinazione delle catene leggere libere nel siero può sostituire la ricerca e quantificazione della proteinuria di Bence Jones nella pratica clinica?

Biochimica Clinica

Volumn 37, Issue 5, 2013, Pages 405-418

  Caldini, Anna ^a   Graziani, Maria Stella ^b  

^a CAREGGI UNIVERSITY HOSPITAL   (Italy)

^b UNIVERSITY HOSPITAL OF VERONA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

BENCE JONES PROTEIN;

CLINICAL PRACTICE; HUMAN; KIDNEY FUNCTION; LIGHT CHAIN; NOTE; PLASMA CELL DYSCRASIA; POEMS SYNDROME; PRACTICE GUIDELINE; PROTEIN DETERMINATION; PROTEINURIA; SCREENING; SERUM FREE LIGHT CHAIN DETERMINATION;

EID: 84889242214     PISSN: 03930564     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Note

References (43)

1. Graziani MS, Merlini G, Petrini C per il GdS SIBioC Proteine. Linee guida per la ricerca della proteina di Bence Jones. Biochim Clin 2001;25:23-32.
2. Graziani MS, Merlini G, Petrini C for the IFCC Committee on Plasma Proteins and the SIBioC Study Group on Proteins. Guidelines for the analysis of Bence Jones protein. Clin Chem Lab Med 2003;41:338-46.
3. Kyle RA, Durie BGM, Rajkumar SV, et al. Monoclonal gammopathy of undetermined significance (MGUS) and smoldering (asymptomatic) multiple myeloma: IMWG consensus perspectives risk factors for progression and guidelines for monitoring and management. Leukemia 2010;24:1121-7.
4. Dimopoulos M, Kyle R, Fermand JP, et al. Guidelines for standard investigative workup: report of the International Myeloma Workshop Consensus Panel 3. Blood 2011;117:4701-5.
5. Tate JR, Mollee P. Towards improved measurement of serum free light chains; clinical and laboratory issues. Biochim Clin 2013;37:395-404.
6. Infusino, Dolci A, Panteghini M. Valutazione delle prestazioni del sistema analitico SPAPLUS per la misura della catene leggere libere del siero. Biochim Clin 2013;37:370-5.
7. Dolci A, Vernocchi A per il Gruppo di Studio SIBioC Proteine. Aspetti metodologici nella ricerca e caratterizzazione delle componenti monoclonali nel siero. Biochim Clin 2012;36:84-9.
8. Linnet K, Bossuyt PMM, Moons GM, et al. Quantifying the accuracy of a diagnostic test or marker. Clin Chem 2012;58:1-10.
9. Pezzati P, Balboni F, Graziani MS. Glossario dei termini per la descrizione-valutazione dell'efficacia clinicoepidemiologica degli esami di laboratorio. Biochim Clin 2010;34:212-7.
10. Bradwell AR, Carr-Smith HD, Mead GP, et al. Highly sensitive, automated immunoassay for immunoglobulin free light chains in serum and urine. Clin Chem 2001;47:673-80.
11. Dispenzieri A, Kyle R, Merlini G et al. International Myeloma Working Group guidelines for serum-free light chain analysis in multiple myeloma and related disorders. Leukemia 2009;23:215-24.
12. Abraham RS, Clark RJ, Bryant SC, et al. Correlation of serum imunoglobulin free light chain quantifiaction with urinary Bence Jones protein in light chain myeloma. Clin Chem 2002;48:655-7.
13. Nowrousian MR, Brandhorst D, Sammet C, et al. Serum free light chain analysis and urine immunofixation electrophoresis in patients with multiple myeloma. Clin Cancer Res 2005;11:8706-14.
14. Katzmann JA, Abraham RS, Dispenzieri A, et al. Diagnostic performance of quantitative kappa and lambda free light chain assay in clinical practice. Clin Chem 2005;51:878-81.
15. Hill PG, Forsyth JM, Rai B, et al. Serum free light chains: an alternative to the urine Bence-Jones proteins screening test for monoclonal gammopathies. Clin Chem 2006;52:1743-8.
16. Katzmann JA, Dispenzieri A, Kyle RA, et al. Elimination of the need for urine studies in the screening algorithm for monoclonal gammopathies by using serum immunofixation and free light chain assay. Mayo Clin Proc 2006;81:1575-8.
17. Beetham R, Wassel J, Wallage MJ, et al. Can serum free light chains replace urine electrophoresis in the detection of monoclonal gammopathies? Ann Clin Biochem 2007;44:516-22.
18. Dispenzieri A, Zhang L, Katzmann JA, et al. Appraisal of imunoglobulins free light chain as a marker of response. Blood 2008;111:4908-15.
19. Fulton RB, Fernando SL. Serum free light chain assay reduces the need for serum and urine immunofixation electrophoresis in the evaluation of monoclonal gammopathy. Ann Clin Biochem 2009;46:407-12.
20. Palladini G, Russo P, Bosoni P. Identification of amyloidogenetic light chains requires the combination of serum-free light chain assay with immunofixation of serum and urine. Clin Chem 2009;55:499-504.
21. Katzmann JA, Kyle RA, Benson J, et al. Screening panels for detection of monoclonal gammopathies. Clin Chem 2009;55:1517-22.
22. Holding S, Spradbery D, Hoole R et al. Use of serum free light chain analysis and urine protein electrophoresis for detection of monoclonal gammopathies. Clin Chem Lab Med 2011;49:83-8.
23. Shaheen SP, Levinson SS. Serum free light chain analysis may miss monoclonal light chains that urine immunofixation electrophoresis would detect. Clin Chim Acta 2009;406:162-6.
24. Levinson SS. Complementarily of urine analysis and serum free light cahin assay for assessing response treatment response: illustrated by three case examples. Clin Chim Acta 2011;412:2206-10.
25. Fabbrini P, Sirtori S, Stella A. Utilizzo della determinazione delle catene leggere libere nel siero in ambito nefrologico. Biochim Clin 2013;37:352-6.
26. Berenson JR, Kenneth KC, Audell RA, et al. Monoclonal gammopathy of undetermined significance: a consensus statement. Br J Haematol 2010;50:28-38.
27. Bird J, Behrens J, Westin J, et al. UK Myeloma Forum (UKMF) and Nordic Myeloma Study Group (NMSG): guidelines for the investigation of newly detected Mproteins and the management of monoclonal gammopathy of undetermined significance (MGUS). Br J Haematol 2010;148:22-42.
28. Munshi NC, Anderson KC, Bergsagel PL, et al. Consensus recommendations for risk stratification in multiple myeloma: report of the International Myeloma Workshop Consensus Panel 2. Blood 2011;117:4696-700.
29. Durie BGM, Harousseau JL, Miguel JS, et al. on behalf of the International Myeloma Working Group. International uniform response criteria for multiple myeloma. Leukemia 2006;20:1467-73.
30. Fernàndez de Larrea C, Kyle RA, Durie BGM, et al. Plasma cell leukemia: consensus statement on diagnostic requirements, response criteria and treatment recommendations by the International Myeloma Working Group. Leukemia 2013;27:780-91.
31. Merlini G, Palladini G. Differential diagnosis of monoclonal gammopathy of undetermined significance. Hematology Am Soc Hematol Educ Program 2012;2012:595-603.
32. Rajkumar SV, Kyle RA, Therneau TM, et al. Serum free light chain ratio is an independent risk factor for progression in monoclonal gammopathy of undetermined significance. Blood 2005;106:812-17.
33. Dispenzieri A, Kyle RA, Katzmann JA, et al. Immunoglobulin free light chain ratio is an independent risk factor for progression of smoldering (asymptomatic) multiple myeloma. Blood 2008;111;785-9.
34. th International Symposium on Amyloid and Amyloidosis. Am J Hem 2005;79:319-28.
35. Dawson MA, Patil S, Spencer A. Extramedullary relapse of multiple myeloma associated with a shift in secretion from intact immunoglobulin to light chains. Haematologica 2007;92:143-4.
36. Merlini G, Palladini G. Le catene leggere libere circolanti nella gestione del paziente con amiloidosi AL. Biochim Clin 2013;37:347-51.
37. Bird J, Cavenagh J, Hawkins P, et al. on behalf of UK Myeloma Forum. Guidelines on the diagnosis and management of AL amyloidosis. Br J Haematol 2004;125:681-700.
38. Lachman HJ, Gallimore GR, Gillmore JD, et al. Outcome in systemic AL amyloidosis in relation to changes in concentration of circulating immunoglobulin free light chains following chemotherapy. Br J Haem 2003;122:78-84.
39. Hutchinson CA, Harding S, Hewins P, et al. Quantitative assessment of serum and urinary polyclonal free light chain in patients with chronic kideny disease. Clin J Am Soc Nephrol 2008;3:1684-90.
40. Maack T, Johnson V, Kau ST, et al. Renal filtration, transport, and metabolism of low-molecular-weight proteins: a review. Kidney Int 1979;16:251-70.
41. Levinson SS. Urine immunofixation electrophoresis remains important and is complementary to serum free light chain. Clin Chem Lab Med 2011;49:1801-4.
42. Merlini G. Serum-free light chain analysis: works in progress. Clin Chem Lab Med 2009;47:1021-2.
43. Albertini R, Merlini G. La misura delle catene leggere libere delle immunoglobuline nel siero: aspetti analitici e clinici. Biochim Clin 2010;34:26-9.